Viewing Study NCT00361374



Ignite Creation Date: 2024-05-05 @ 5:01 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00361374
Status: COMPLETED
Last Update Posted: 2014-07-18
First Post: 2006-08-04

Brief Title: Safety and Effectiveness of Omega 3-Fatty Acids EPA Versus DHA for the Treatment of Major Depression
Sponsor: Massachusetts General Hospital
Organization: Massachusetts General Hospital

Study Overview

Official Title: Omega-3 Fatty Acids for Treatment of Major Depression Differential Effects of EPA and DHA and Associated Biochemical and Immune Parameters
Status: COMPLETED
Status Verified Date: 2014-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study examines the difference in the effectiveness of two natural compounds eicosapentanoic EPA and docosahexanoic DHAomega-3 fatty acids in treating major depressive disorder Both types of omega-3 fatty acids are commonly found in fish oils It is believed that a deficiency in these omega-3 fatty acids may lead to the development of major depression
Detailed Description: The study lasts for eight weeks and involves four visits after the screen and baseline visits biweekly Participants will be randomized or chosen by chance to enter into one of three groups People in the first group will take 1 gday or EPA omega-3 fatty acid those in the second group will take 1 gday of DHA omega-3 fatty acid and those in the third group will take a placebo This study is double-blind which means that neither the participant nor the doctor nor the research staff will know which group each person is in At the end of the study the participant will be offered three months of follow-up care at the Depression Clinical and Research Program

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
5R01MH074085 NIH None httpsreporternihgovquickSearch5R01MH074085